Emerging therapeutic targets in ovarian cancer / (Record no. 14341)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04854cam a2200733Ia 4500 |
001 - CONTROL NUMBER | |
control field | ocn694733434 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20171224115040.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cn||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 110103s2011 nyua ob 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | GW5XE |
Language of cataloging | eng |
Description conventions | pn |
Transcribing agency | GW5XE |
Modifying agency | EBLCP |
-- | OCLCQ |
-- | MHW |
-- | OCLCQ |
-- | OCLCF |
-- | OCLCQ |
-- | E7B |
-- | N$T |
-- | RRP |
-- | OCLCO |
-- | YDXCP |
-- | DEBSZ |
-- | OCLCO |
-- | DG1 |
-- | OCLCO |
-- | OCLCQ |
-- | OCLCO |
-- | OCLCQ |
-- | DEBBG |
-- | DG1 |
066 ## - CHARACTER SETS PRESENT | |
Alternate G0 or G1 character set | (S |
019 ## - | |
-- | 698589443 |
-- | 748435289 |
-- | 771448200 |
-- | 798698956 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781441972163 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 1441972161 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781441972156 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 1441972153 |
Qualifying information | (electronic bk.) |
029 1# - (OCLC) | |
OCLC library identifier | AU@ |
System control number | 000048771752 |
029 1# - (OCLC) | |
OCLC library identifier | AU@ |
System control number | 000049595547 |
029 1# - (OCLC) | |
OCLC library identifier | DEBSZ |
System control number | 430928793 |
029 1# - (OCLC) | |
OCLC library identifier | GBVCP |
System control number | 790038005 |
029 1# - (OCLC) | |
OCLC library identifier | NZ1 |
System control number | 13777845 |
029 1# - (OCLC) | |
OCLC library identifier | NZ1 |
System control number | 15921957 |
029 1# - (OCLC) | |
OCLC library identifier | DEBBG |
System control number | BV043392620 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)694733434 |
Canceled/invalid control number | (OCoLC)698589443 |
-- | (OCoLC)748435289 |
-- | (OCoLC)771448200 |
-- | (OCoLC)798698956 |
037 ## - SOURCE OF ACQUISITION | |
Stock number | 978-1-4419-7215-6 |
Source of stock number/acquisition | Springer |
Note | http://www.springerlink.com |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC280.O8 |
Item number | E44 2011 |
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | 2011 B-194 |
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | WP 322 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | HEA |
Subject category code subdivision | 039030 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 062000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.99/465 |
Edition number | 22 |
049 ## - LOCAL HOLDINGS (OCLC) | |
Holding library | MAIN |
245 00 - TITLE STATEMENT | |
Title | Emerging therapeutic targets in ovarian cancer / |
Statement of responsibility, etc | Stan Kaye [and others], editors. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | New York : |
Name of publisher, distributor, etc | Springer Science+Business Media, LLC, |
Date of publication, distribution, etc | ©2011. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (xiii, 291 pages) : |
Other physical details | illustrations |
336 ## - | |
-- | text |
-- | txt |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | c |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | cr |
-- | rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer. |
520 ## - SUMMARY, ETC. | |
Summary, etc | This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers. |
588 0# - | |
-- | Print version record. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Ovaries |
General subdivision | Cancer |
-- | Treatment. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Ovarian Neoplasms |
General subdivision | therapy. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antineoplastic Agents |
General subdivision | therapeutic use. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug Design. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug Therapy |
General subdivision | trends. |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Medicine. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | HEALTH & FITNESS |
General subdivision | Diseases |
-- | Cancer. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Oncology. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Ovaries |
General subdivision | Cancer |
-- | Treatment. |
Source of heading or term | fast |
-- | (OCoLC)fst01049287 |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kaye, Stanley B. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Display text | Print version: |
Title | Emerging therapeutic targets in ovarian cancer. |
Place, publisher, and date of publication | New York : Springer, ©2011 |
International Standard Book Number | 9781441972156 |
Record control number | (OCoLC)702604723 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://onlinelibrary.wiley.com/book/10.1002/9781118185537">http://onlinelibrary.wiley.com/book/10.1002/9781118185537</a> |
Public note | Wiley Online Library |
880 0# - ALTERNATE GRAPHIC REPRESENTATION | |
Linkage | 505-00/(S |
a | Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs / Susana Banerjee, Michael A. Bookman, and Martin Gore -- Discovery of Novel Targets / John Farley and Michael J. Birrer -- Novel Anti-angiogenic Therapies in Ovarian Cancer / Jurjees Hasan and Gordon Jayson -- Targeting the AKT Pathway in Ovarian Cancer / Euan A. Stronach [and others] -- Inhibition of the Src Oncogene : Therapeutic Potential in Ovarian Carcinoma / Liz Y. Han and Anil K. Sood -- Tumour-Specific Synthetic Lethality : Targeting BRCA Dysfunction in Ovarian Cancer / Timothy A. Yap [and others] -- Targeting Inflammatory Pathways in Epithelial Ovarian Cancer / Jermaine Coward and Frances Balkwill -- Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer : Moving Forward in the Era of Molecularly Targeted Therapy / Lainie P. Martin, Julia J. Perkins, and Russell J. Schilder -- Epigenetic Therapies / Robert Brown, Nadine Chapman-Rothe, and Ros Glasspool -- Ovarian Cancer Immunology and Immunotherapy / Sadaf Ghaem-Maghami and Martin Gore -- Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential / Susan K. Murphy and Andrew Berchuck -- Potential for α-Folate Receptor-Targeted Treatment for Ovarian Cancer / Chau H.M. Ng and Ann L. Jackman -- New Insights into Tubulin Binders / Carles Escriu and James D. Brenton. |
938 ## - | |
-- | EBL - Ebook Library |
-- | EBLB |
-- | EBL645306 |
938 ## - | |
-- | ebrary |
-- | EBRY |
-- | ebr10432326 |
938 ## - | |
-- | EBSCOhost |
-- | EBSC |
-- | 371375 |
938 ## - | |
-- | YBP Library Services |
-- | YANK |
-- | 3547519 |
994 ## - | |
-- | 92 |
-- | DG1 |
No items available.